"Evaluating small bowel wall in Crohn's disease: a comparison of MR enterography and contrast-enhanced ultrasound"

"Evaluating small bowel wall in Crohn's disease: a comparison of MR enterography and contrast-enhanced ultrasound" - "Contrast-enhanced ultrasound in the diagnosis of Crohn's disease"

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33145

Enrollment

150

Registered

2009-07-13

Start date

2009-09-15

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease Inflammatory bowel disease

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age between 18-65 years old; - confirmed Crohn*s disease by ileocolonoscopy with biopsies; - informed consent;

Exclusion criteria

Exclusion criteria: - cardiac failure (acute or chronic NYHA class II -IV) or other heart disease (unstable angina pectoris, recent acute coronary syndrome, severe rhythm disorders), right-to-left cardiac shunts, uncontrolled systemic hypertension, severe pulmonary hypetension and adult respiratory distress syndrome, which contraindicate the use of intravenous contrast during CE-US; - chronic end stage kidney disease (risk for nephrogenic systemic sclerosis by use of MRI contrast agent: Gadolinium); - patients having absolute contraindications for the MRI (intracorporal metal clips, neurostimulator, insuline pomp or pacemaker); - patients with an acute abdomen and indication for surgery; - pregnancy and lactation;

Design outcomes

Primary

Measure	Time frame
The disease activity scores at CE-US (qualitative and quantitative), MRE and ileocolonoscopy and clinical activity score.	—

Countries

Netherlands

Outcome results